Equities

I'rom Group Co Ltd

2372:TYO

I'rom Group Co Ltd

Actions
Health CareHealth Care Providers
  • Price (JPY)2,598.00
  • Today's Change2.00 / 0.08%
  • Shares traded8.50k
  • 1 Year change+34.54%
  • Beta1.1772
Data delayed at least 20 minutes, as of Nov 22 2024 06:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in JPYIncome statement in JPYView more

Year on year I'rom Group Co Ltd's revenues fell -3.33% from 18.35bn to 17.74bn. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from 2.54bn to 1.42bn, a -44.34% decrease.
Gross margin39.63%
Net profit margin1.44%
Operating margin2.34%
Return on assets0.72%
Return on equity2.02%
Return on investment1.10%
More ▼

Cash flow in JPYView more

In 2024, cash reserves at I'rom Group Co Ltd fell by 2.15bn. However, the company earned 448.00m from its operations for a Cash Flow Margin of 2.53%. In addition the company generated 163.00m cash from financing while 2.78bn was spent on investing.
Cash flow per share121.50
Price/Cash flow per share21.77
Book value per share1,044.22
Tangible book value per share973.02
More ▼

Balance sheet in JPYView more

I'rom Group Co Ltd has a Debt to Total Capital ratio of 59.48%, a lower figure than the previous year's 75.13%.
Current ratio1.21
Quick ratio1.15
Total debt/total equity1.47
Total debt/total capital0.5948
More ▼

Growth rates in JPY

Year on year, both dividends per share and earnings per share excluding extraordinary items growth dropped -20.00% and -44.35%, respectively. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.
Div yield(5 year avg)2.22%
Div growth rate (5 year)14.87%
Payout ratio (TTM)0.00%
EPS growth(5 years)9.08
EPS (TTM) vs
TTM 1 year ago
-84.37
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.